Bourdage Becomes COO As Sandoz Shuffles Management

Chief Business Officer Carol Lynch Departs As Hayling Becomes CSO

 
• By David Wallace
  
Pierre Bourdage, Sandoz head of biopharmaceuticals
Pierre Bourdage is now COO of Sandoz • Source: Sandoz
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Leadership

More from Generics Bulletin